Business profile

Eero Therapeutics Oy

Eero Therapeutics Oy's registered office is Helsingfors. It is a limited company. The company was established on 2019-07-22. It operates in the industry of other miscellaneous educational n.e.c.. In its latest retained statement for 2019-12-31, revenue was €1,200 and operating profit was €15.

Claim profileContact details
Business ID 3013096-5ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3013096-5
Sector
Other miscellaneous educational n.e.c.
Municipality
Helsingfors
Company form
Limited company
Registration date
2019-07-22
Business ID registration date
2019-07-17
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Pengerkatu 17 C 92, 00500, Helsingfors

Phone: +358504654004Source observation

Email: [email protected]Source observation

Website: https://eero-therapeutics.fiSource observation

People and decision-makers

Heino Eero JuhaniToimitusjohtaja

About Eero Therapeutics Oy

Financial position and key figures for the company.

Eero Therapeutics Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2019-07-22. It operates in the industry of other miscellaneous educational n.e.c.. In its latest retained statement for 2019-12-31, revenue was €1,200 and operating profit was €15. The latest retained financial statement for 2019-12-31 shows revenue of €1,200 and profit for the financial year of €12. Based on the latest retained statement, revenue growth was not currently available, operating margin was +1.3%, and equity ratio was +1.0%.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2019-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Operating margin1.3%
Equity ratio1.0%
Revenue€1,200Previous comparison not availablePrevious: No comparison value
Operating profit (loss)€15Previous comparison not availablePrevious: No comparison value
Profit (loss) for the financial year€12Previous comparison not availablePrevious: No comparison value
Assets€1,236Previous comparison not availablePrevious: No comparison value
Balance-sheet contextLatest financial period
Profit before taxes€15Previous: No comparison value
Employees1Previous: No comparison value

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioWeak
1/100 · Trend unavailable
1.0 %Comparison period is not available from the source
Current ratioNot assessable
0/100 · Trend unavailable
Not availableComparison period is not available from the source
Operating profit marginPassable
53/100 · Trend unavailable
1.3 %Comparison period is not available from the source

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3013096-5
EU IDFIFPRO.3013096-5
MunicipalityHelsingfors
Current registered entries
2019-07-22Registered in Tax Administration (Tax Administration)
2019-07-22Registered in Patent and Registration Office (Trade Register)

Responsible people

Public role relationships materialized from source observations.

Heino Eero JuhaniToimitusjohtajaSources: 4 · Confidence: 78%
Heino Eero JuhaniVarsinainen jäsenSources: 2 · Confidence: 78%
Heino Hannele TuijaVarajäsenSources: 2 · Confidence: 78%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B2
SatisfactoryEero Therapeutics Oy
Grade upgradedB3 → B2 · new analysis 2026-10-17
Model score50/100
Assessment confidenceLow
Evidence qualityUsable financial evidenceFinancial data included
Peer comparisonSame industry, size and age groupDescriptive comparison – does not change the model score.
64 peers
Solvency22%
Below 78% of peers
Profitability45%
Below 55% of peers
Supporting factors
  • Active registered status
  • A newer financial statement filing has been reported
  • Lower industry distress context
Risk factors to note
  • Parsed financial metrics are older than the newest reported filing
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
2 assessments
B2
2026-10-1750/100 · v0.15
B3 → B2 · +2 points
  • Risk factor cleared: High balance-sheet leverage.
B3
2026-09-2148/100 · v0.14
Oldest retained automatic assessment in this comparison
Automatic model gradeB2
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry risklow
77/100

Industry context is low based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 7 years of registry continuity.

Registry and status signalsRajallinen
38/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.
Risk grade updatedRisk gradeEvidence verified
21 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B3.

Registry timeline

Trade register notifications shown on a timeline.

3 register eventsLatest event: 2025-11-13

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Eero Therapeutics Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.